Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

The 5 days of training include a comprehensive overview of the core processes and systems in place and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.

戻る Agenda

Joint MHRA/DIA Excellence in Pharmacovigilance: Clinical Trials and Post-Marketing

Topic 2 Session 1 continued: SUSAR Reporting in Clinical Trials and Case Studies

最新情報や機会を逃さないで